UTXO Data Challenges Traditional Cycle Narratives

Bitcoin is trading above the $71,000 level as the market navigates heightened volatility, reflecting a phase of uncertainty following recent price swings. While short-term momentum remains unstable, underlying on-chain data suggests that the current market structure may differ significantly from…

Avalo Therapeutics 2025 Financial Review

[ad_1] Company Overview Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases. The company’s lead asset, abdakibart, is currently advancing through a Phase 2 clinical trial for hidradenitis suppurativa. Key Financial Figures For…